- Home
- WKSP vs PMN Comparison
WKSP vs PMN Comparison
Compare WKSP & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKSP
- PMN
- Stock Information
- Founded
- WKSP 2003
- PMN 2004
- Country
- WKSP United States
- PMN Canada
- Employees
- WKSP N/A
- PMN N/A
- Industry
- WKSP Auto Parts:O.E.M.
- PMN Pharmaceuticals and Biotechnology
- Sector
- WKSP Consumer Discretionary
- PMN Health Care
- Exchange
- WKSP Nasdaq
- PMN Nasdaq
- Market Cap
- WKSP 14.6M
- PMN 17.0M
- IPO Year
- WKSP N/A
- PMN N/A
- Fundamental
- Price
- WKSP $3.04
- PMN $0.49
- Analyst Decision
- WKSP Strong Buy
- PMN Strong Buy
- Analyst Count
- WKSP 3
- PMN 2
- Target Price
- WKSP $12.83
- PMN $4.50
- AVG Volume (30 Days)
- WKSP 167.1K
- PMN 39.5K
- Earning Date
- WKSP 08-12-2025
- PMN 08-07-2025
- Dividend Yield
- WKSP N/A
- PMN N/A
- EPS Growth
- WKSP N/A
- PMN N/A
- EPS
- WKSP N/A
- PMN N/A
- Revenue
- WKSP $10,211,747.00
- PMN N/A
- Revenue This Year
- WKSP $159.92
- PMN N/A
- Revenue Next Year
- WKSP $68.25
- PMN N/A
- P/E Ratio
- WKSP N/A
- PMN N/A
- Revenue Growth
- WKSP 407.96
- PMN N/A
- 52 Week Low
- WKSP $2.44
- PMN $0.47
- 52 Week High
- WKSP $12.00
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- WKSP 50.62
- PMN 45.60
- Support Level
- WKSP $2.87
- PMN $0.48
- Resistance Level
- WKSP $3.11
- PMN $0.53
- Average True Range (ATR)
- WKSP 0.25
- PMN 0.02
- MACD
- WKSP -0.01
- PMN 0.00
- Stochastic Oscillator
- WKSP 36.05
- PMN 26.86
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.